1030sek
-4,6 %
Date:2026-03-09Time:18:00:00Latest report:Q4-2025List:First NorthTicker:FLUI
Market Cap:14 msekEnterprise Value:12 msekNet Sales:6,00 msekEarnings:-8,33 msekEmployees:0ISIN:SE0023595459

Ratios

10-year key figure history for Fluicell turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Fluicell with index and moving average MA50 and MA200.

Stockprice:10,30
MA50:10,04
MA200:11,46
Price/MA200:-10,1 %
RSI (14):49,5
Price/MA50:2,6 %

Description

Fluicell operates in biotechnology. The company conducts research and development in the processing of cell composition in the development of new drugs. The company has developed a product portfolio consisting of patented research instruments, which are used to study, analyze and ultimately process cells. In addition, there is expertise in 2D/3D printing. Fluicell was founded in 2012 and is headquartered in Gothenburg.

Biotechnology